Skip to main content
Livermore
Livermore
ZHEN

VeraBank, N.A.

SEC CIK
0001767297
Latest filing
Aug 5, 2026

ABT holding history

Abbott Laboratories in every 13F filed by VeraBank, N.A., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
19,393
Value
$1.76M
% of portfolio
0.3%
Quarters held
22
Since Q1 2021
Holdings of ABT by VeraBank, N.A., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202619,393$1.76M0.3%−280−1.4%ReducedHolders
Q1 202619,673$2.02M0.4%−422−2.1%ReducedHolders
Q4 202520,095$2.52M0.5%−72−0.4%ReducedHolders
Q3 202520,167$2.70M0.5%−77−0.4%ReducedHolders
Q2 202520,244$2.75M0.6%+810+4.2%AddedHolders
Q1 202519,434$2.58M0.7%−203−1.0%ReducedHolders
Q4 202419,637$2.22M0.6%−65−0.3%ReducedHolders
Q3 202419,702$2.25M0.7%−144−0.7%ReducedHolders
Q2 202419,846$2.06M0.6%00.0%UnchangedHolders
Q1 202419,846$2.26M0.7%−71−0.4%ReducedHolders
Q4 202319,917$2.19M0.7%−59−0.3%ReducedHolders
Q3 202319,976$1.93M0.7%00.0%UnchangedHolders
Q2 202319,976$2.18M0.8%−1,062−5.0%ReducedHolders
Q1 202321,038$2.13M1.0%−1,292−5.8%ReducedHolders
Q4 202222,330$2.45M1.2%−300−1.3%ReducedHolders
Q3 202222,630$2.19M1.4%00.0%UnchangedHolders
Q2 202222,630$2.46M1.4%+307+1.4%AddedHolders
Q1 202222,323$2.64M1.4%−781−3.4%ReducedHolders
Q4 202123,104$3.25M1.6%00.0%UnchangedHolders
Q3 202123,104$2.73M1.5%00.0%UnchangedHolders
Q2 202123,104$2.68M1.6%+111+0.5%AddedHolders
Q1 202122,993$2.76M1.8%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.